Laboratory real-time biomarkers for immune related adverse events in immunotherapies of patients with metastasized malignant melanoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Köln, Universität zu Köln, Dissertation, 2019
- Schlagwort
-
Melanoma
Biochemical markers
Patients
Time
- Ereignis
-
Veröffentlichung
- (wo)
-
Köln
- (wer)
-
Deutsche Zentralbibliothek für Medizin
- (wann)
-
2019
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.4126/FRL01-006415491
- URN
-
urn:nbn:de:hbz:38m-frl:64154910
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gerecht, Lukas Jan
- Streichert, Thomas
- Schlaak, Max Simon
- Deutsche Zentralbibliothek für Medizin
Entstanden
- 2019
Ähnliche Objekte (12)
Pathology of malignant melanoma
Immunotherapy of malignant melanoma
Pathobiology of malignant melanoma
Epidemiology of malignant melanoma
Management of Malignant Melanoma
Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors
Towards the generation of novel natural killer cell-based immunotherapies against melanoma
Towards the Generation of novel Natural Killer Cell-based Immunotherapies against Melanoma
Gastric metastases from malignant melanoma
METASTATIC MALIGNANT MELANOMA OF SKIN
Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review
Evaluating necroptosis competency in malignant melanoma
Pathology of malignant melanoma
Immunotherapy of malignant melanoma
Pathobiology of malignant melanoma
Epidemiology of malignant melanoma
Management of Malignant Melanoma
Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors
Towards the generation of novel natural killer cell-based immunotherapies against melanoma
Towards the Generation of novel Natural Killer Cell-based Immunotherapies against Melanoma
Gastric metastases from malignant melanoma
METASTATIC MALIGNANT MELANOMA OF SKIN
Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review
Evaluating necroptosis competency in malignant melanoma
Pathology of malignant melanoma
Immunotherapy of malignant melanoma
Pathobiology of malignant melanoma
Epidemiology of malignant melanoma
Management of Malignant Melanoma
Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors
Towards the generation of novel natural killer cell-based immunotherapies against melanoma
Towards the Generation of novel Natural Killer Cell-based Immunotherapies against Melanoma
Gastric metastases from malignant melanoma
METASTATIC MALIGNANT MELANOMA OF SKIN
Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review